Medicine & Life Sciences
Nitric Oxide
100%
Cytochrome Reductases
47%
Community-Institutional Relations
45%
Cytochromes b5
44%
Pulmonary Hypertension
42%
Propylthiouracil
41%
Pulmonary Fibrosis
35%
Umbilical Cord
35%
Adult Respiratory Distress Syndrome
33%
Pulmonary Artery
28%
Biological Availability
27%
Mesenchymal Stem Cells
27%
Organizations
25%
Hemoglobins
24%
Placebos
21%
Randomized Controlled Trials
20%
Blood Vessels
18%
Lung
16%
Exercise
16%
Metalloproteins
9%
Population
9%
Maintenance
8%
Safety
8%
Ideal Body Weight
7%
Arteries
7%
Idiopathic Pulmonary Fibrosis
7%
Therapeutics
7%
Drug Development
7%
Myography
7%
Endothelial Cells
7%
Substance-Related Disorders
6%
Interstitial Lung Diseases
6%
Pathologic Processes
6%
Smooth Muscle Myocytes
6%
Life Expectancy
6%
Peptides
6%
Nitric Oxide Synthase
5%
Referral and Consultation
5%
Nurses
5%
Research Personnel
5%
HIV
5%
Chemical Compounds
Nitric Oxide
87%
Bioavailability
30%
Hemoglobin
28%
Diffusion
26%
Modification
17%
Peptide
11%
Molecule
10%
Metalloprotein
7%
Hypertensive
7%
Reactive Oxygen Metabolite
5%
Acetylcholine
5%